Proposal would extend treatment access to pediatric patients weighing 5 kg and aboveMINNEAPOLIS, May 14, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed ...
The framework would leverage existing safety data on approved drugs to provide new options to patients with unmet medical ...
Discover the top Korean Botox brands to watch in 2026, known for innovation, affordability, and growing influence in the ...
Subpoenas demanded birthdays, social security numbers and addresses of patients who got gender-affirming care ...
New research suggests a bombshell claim from Mel Gibson on influencer Joe Rogan’s popular podcast may have helped fuel a ...
Ivermectin prescriptions spiked among cancer patients after Mel Gibson endorsed antiparasitic drugs on Joe Rogan's podcast, a ...
Investigational New Drug application for KHN921 received 'study may proceed” from the US FDA. KHN921 is a potential 'first-in-class' cardiovascular AAV gene therapy being developed for the treatment o ...
I thought I was going crazy.” For years, patients were told that coming off antidepressants was straightforward: taper over a ...
Explore the 9 best supplement packaging design companies helping emerging wellness brands create standout, compliant, and ...
Papzimias: A first-in-class FDA-approved gene therapy indicated for adult patients with recurrent respiratory papillomatosis (RRP), based on a proprietary adenovector technology platform. AdenoVerse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results